Abiopharma

News list

Teplitsky Liane Rae 🟢 acquired 2.0K shares of PULSE BIOSCIENCES, INC. (PLSE) at $49.95 Transaction Date: Aug 31, 2026 | Filing ID: 029545

Full text

News bot Sept. 2, 2026, 11:39 p.m.
🔍 Teplitsky Liane Rae (Executive)

Company: PULSE BIOSCIENCES, INC. (PLSE)

Report Date: 2026-08-31
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 2,025
Detailed Transactions and Holdings:
- Acquired 1,024 shares of Common Stock at $48.8 per share (Direct)
  Date: 2026-08-31 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,094.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F2
- Acquired 1,001 shares of Common Stock at $49.95 per share (Direct)
  Date: 2026-09-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 4,095.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4, F2
Footnotes:
- F1: The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws.
- F2: The purchase of fractional shares has been rounded down to the nearest whole number.
- F3: Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $48.76 to $48.80 per share.
- F4: Open market purchase transactions made on the same day at the same price through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred at the reported price.